Purpose: The goal of this study was to define a new homogeneity index (HI) to evaluate dose homogeneity within a target volume.
future technology and treatment protocols. In turn, this can help us to find the means by which treatment plans can be improved in future.
Several HIs have been reported in the literature, [9] [10] [11] [12] [13] including D max /D p , D 5 /D 95 , (D 2 − D 98 )/D p , (D 2 − D 98 )/D 50 , and S-index. The conventional HI of D max /D p is defined as the ratio of the maximum dose (D max ) in the target volume to the prescribed dose (D p ), with a value closer to one indicating better homogeneity. 9 The D max value is sensitive to calculation parameters, such as grid size and grid placement, so the D max /D p index may not be reliable. The HI of D 5 /D 95 , choosing the minimum dose in a target volume rather than a dose point, is described as the ratio of the minimum dose in 5% of the target volume (D 5 ) to the minimum dose in 95% of the target volume (D 95 ). 10 Another HI is calculated as (D 2 − D 98 )/D p , 11 where D 2 and D 98 are the minimum dose covering 2% and 98% of the target volume respectively, although report 83 of the ICRU suggests (D 2 − D 98 )/D 50 instead, 12 with D 50 being the normalization value. Lower values of (D 2 − D 98 )/D p and (D 2 − D 98 )/D 50 indicate a more homogeneous dose distribution. It should be noted that the HIs of D max /D p , D 5 /D 95 , (D 2 − D 98 )/D p , and (D 2 − D 98 )/D 50 are usually based on two or three points of the dose volume histogram (DVH) curve, and do not reflect information from the whole DVH. Differing from the above mentioned HIs, the S-index proposed by Yoon et al. 13 takes the whole DVH into consideration, using the standard deviation of the differential DVH curve to quantify the dispersion of the average dose of the target volume. While the information contained in the S-index is relatively unitary, the S-index only reflects information from the achieved dose-volume histogram curve (A-DVH); it does not make reference to any information from the prescribed dose. 14 
An ideal HI for evaluating radiotherapy plans should objectively
and accurately reflect the dose distribution. We therefore developed a new HI to evaluate the dose homogeneity of the radiotherapy plans, incorporating information from the ideal dose-volume histogram (I-DVH) curve and the A-DVH curve, and we demonstrate its application to two clinical examples. In addition, we evaluated the percentage accuracy of the new HI and D max /D p , D 5 /D 95 , (D 2 − D 98 )/ D p , (D 2 − D 98 )/D 50 and S-index.
| MATERIALS AND METHOD

2.A | Definition of the new HI
The ideal DVH for a target volume would be a step function, with 100% of the target receiving exactly the prescribed dose. However, the A-DVH deviates from this step function. The new HI can be defined as:
where IA is the area under the I-DVH curve, AA is the area under the A-DVH curve, and OA is the overlapping area between IA and AA. The relationship between IA, AA, and OA is shown in Fig. 1 
where V is the target volume. Formula (2) depends on the prescribed doses and the volumes of the targets, and does not depend on the other variables of the radiotherapy plan. If a plan has only one steep dose gradient, formula (2) for the I-DVH is simplified into a unit step function, and the I-DVH of PTV 1 is shown in Fig. 2 . If a plan has two steep dose gradients and two target volumes, the I-DVH of PTV 1 is simplified into a second-order step function. The I-DVH of PTV 1 and PTV 2 are shown in Fig. 3 . The homogeneity of the pair of plans was first evaluated by three physicists, with their judgments being considered as the evaluation standard for this study. In order to ensure that physicists were not disturbed by other dosimetric parameters when evaluating the dose homogeneity of the radiotherapy plans, only the DVH curves of the targets were afforded to them. The physicists were required to make one of three judgments: plan A was superior to plan B, plan
2.C | Evaluation of the new HI's performance
A was inferior to plan B, or plan A was equivalent to plan B. If the three physicists gave three different opinions, the case was excluded. If the three physicists' evaluations were consistent or two of three physicists' evaluations were consistent, then the consistent evaluation result was used as the evaluation criteria of this study.
The new HI and the other indices of D max /D p , D 5 /D 95 , (D 2 − D 98 )/D p , (D 2 − D 98 )/D 50 and S-index were also used to evaluate the homogeneity of the pair of radiotherapy plans. If the evaluation by the HI agreed with the judgments of the physicists, it was considered that the HI evaluation was accurate for that case, and if it was otherwise, it was considered inaccurate. The ratio of the number of accurate evaluations to the total number of evaluations was used to define the percentage accuracy. From the total of 88 cases, 4 cases were discarded, leaving 84 cases to be evaluated.
2.D | Statistical analysis
To determine whether there is a significant difference among the percentage accuracies of evaluation for the new HI, Table 2 . The lowest evaluation percentage accuracy was found with D max /D p , and the highest with the new HI. The newly defined HI had the highest accuracy of all the HIs, and this difference was statistically significant (P < 0.05).
3.B | Percentage accuracy of the evaluations
We made a statistical analysis for the values of the new HI, D max /D p , Table 3 .
| DISCUSSION
In this study, we defined a new HI and evaluated it alongside previ- the new HI, thereby provide a potential improvement in the accurate evaluation of radiotherapy plans.
The impact of an increase in the number of prescribed doses in the radiotherapy plan on the dose homogeneity evaluated by HIs has not been addressed in previous literature. The new HI would be likely to provide more accurate evaluations compared with the previously described HIs because as the prescribed dose increases, the evaluations of the homogeneity would be more complex, while the new HI could avoid the problem as the IA is included as a parameter within it.
It should be noted that the percentage accuracy results are based on the interpretations of the physicists. We could not predict the accuracy of a physicist's assessment, so we therefore used three physicists to evaluate the homogeneity of each radiotherapy plan. The evaluations of three physicists are likely to be more accurate than those of a single physicist, and we eliminated those cases where the three physicists disagreed with each other. Although in this paper, the evaluations of three physicists are used as criteria to evaluate the accuracy of other methods for calculating the HI, we still cannot use them to evaluate the plans instead of using the proposed new and other methods to determine HI in clinical work. First, if the homogeneity of each plan is evaluated by three physicists, it will greatly increase the cost of manpower. Secondly, the physicist's judgment is only a qualitative evaluation, but it cannot give a specific quantitative evaluation.
Despite the benefits described above, the new HI also has limitation, and its evaluation sensitivity is not as high as the S-index. This may affect the percentage accuracy of the evaluation. If two achieved DVHs are a little different, the quantitative evaluations achieved using the new HI could be the same. Therefore, further work to improve the sensitivity of the evaluation is necessary.
| CONCLUSIONS
In the present study, a new HI definition is given, one which evalu- 
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